Adding the antiangiogenic drug to standard care does not extend overall survival among patients with metastatic esophageal ...

A major European clinical research event in oncology gives a boost to antibody–drug conjugates, treatments that work like a Trojan horse, delivering chemotherapy to the interior of malignant cells ...

Patients with advanced triple negative breast cancer ineligible for immunotherapy may overcome their typically poor prognosis with antibody-drug conjugates, suggest two trials presented at ESMO 2025.

Why are lobular breast cancers found at later stages? What are the biological hallmarks of this disease? Are there ways to ...

A TV presenter with stage 4 breast cancer has said she's had to "battle" for care. Mum-of-three Mari Grug, 41, was diagnosed ...

Sometimes the unintended consequences of a treatment can seem worse than the disease. That's certainly the case for patients ...

A chef who was diagnosed with an aggressive form of breast cancer after discovering a lump is urging all men to “check their ...

The American Cancer Society is going beyond solely identifying the issue of financial toxicity; they’re actively working to ...

MILLI Tanner went to her GP 13 times before doctors finally discovered she had a deadly cancer she’d been told she was too ...

Mail-in stool kits such as Colorguard can detect warning signs, but gastroenterologists say a colonoscopy is still the most ...

Alecensa (alectinib) demonstrated a 22% reduction in the risk of death compared with Xalkori (crizotinib) in the frontline ...